Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CDAC Study - Cerebral Dysfunction After Coronary Revascularization

NCT07491120 is registered in ClinicalTrials.gov with The Scripps Research Institute as lead sponsor.

NCT NCT07491120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07491120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CDAC Study - Cerebral Dysfunction After Coronary Revascularization
Lead sponsor
The Scripps Research Institute
Phase
Observational
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
January 1, 2033
Enrollment
600 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cabg, cognitive decline, pci